Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen lässt, finden Patienten Informationen zu Behandlungsmöglichkeiten, die Namen von Fachleuten...
Read More
For the first time in a pandemic, Artificial Intelligence (AI) is playing a role like never before in areas ranging from diagnosing risk to doubt-clearing, from delivery of services to...
Read More
Disclaimer: This press release and our findings are solely intended as information for the scientific community. This content is not intended to be a substitute for professional medical advice or...
Read More
Innoplexus wins Silver Edison Award for OntosightⓇ Explore Frankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary OntosightⓇ Explore platform....
Read More
Innoplexus has been a leading contributor to big data and Artificial Intelligence (AI) projects in pharma R&D. Our point of view on the impact of AI enabled technologies on R&D...
Read More
Over the past several years, there’s been an exponential increase in the level of clinical trial complexity, ironically amidst technological advancement. Only one in five candidates makes it from phase...
Read More
